Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy Subjects

NCT02182037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Single rising doses of BIBT 1011 BS
DRUG: BIBT 1011 BS placebo

Sponsor

Boehringer Ingelheim